Table S1 from PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma

Authors:

Open Access

Supplementary Table 1 shows enriched gene sets upregulated in CAOV3 cells treated with talazoparib.